- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03875833
Prospective Analysis of Effect of Collagen Wrap Conduit on Radial and Ulnar Nerve Function Following Radial/Ulnar Forearm Free Flap Harvest
May 18, 2023 updated by: James C Melville, The University of Texas Health Science Center, Houston
The purpose of this study is to determine whether collagen nerve conduits placed on exposed radial and ulnar nerves during radial and ulnar forearm free flap harvests will reduce the occurrence and degree of sensory nerve deficit.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: James C Melville, DDS
- Phone Number: 713-500-7831
- Email: James.C.Melville@uth.tmc.edu
Study Contact Backup
- Name: Simon W Young, DDS
- Phone Number: 713-486-4253
- Email: Simon.Young@uth.tmc.edu
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- Recruiting
- The University of Texas Health Science Center at Houston
-
Contact:
- James C Melville, DDS
- Phone Number: 713-500-7831
- Email: James.C.Melville@uth.tmc.edu
-
Contact:
- Simon W Young, DDS
- Phone Number: 713-486-4253
- Email: Simon.Young@uth.tmc.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- patients present with a complex defect after tumor resection
- all these cases done with the departments of Oral and Maxillofacial Surgery and Otolaryngology at the University of Texas in multiple locations that include, Memorial Hermann Hospital, Ben Taub General Hospital, Lyndon B. Johnson General Hospital and The Methodist hospital.
- patients that have been diagnosed with head and neck tumors and who will undergo a composite resection and reconstruction with radial or ulnar free vascularized flap.
Exclusion Criteria:
- pre-existing nerve deficits
- pregnant women
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control
|
|
Experimental: Collagen Nerve Wrap Conduit
|
The collagen nerve wrap conduit will be placed on all exposed radial and ulnar nerves at the time of free flap harvest.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of participants with normal sensory recovery at the site of forearm free flap as assessed by subjective patient questionnaire regarding upper extremity sensation and function
Time Frame: baseline
|
baseline
|
|
Number of participants with normal sensory recovery at the site of forearm free flap as assessed by subjective patient questionnaire regarding upper extremity sensation and function
Time Frame: 3 months
|
3 months
|
|
Number of participants with normal sensory recovery at the site of forearm free flap as assessed by subjective patient questionnaire regarding upper extremity sensation and function
Time Frame: 6 months
|
6 months
|
|
Number of participants with normal sensory recovery at the site of forearm free flap as assessed by subjective patient questionnaire regarding upper extremity sensation and function
Time Frame: 12 months
|
12 months
|
|
Number of participants with normal sensory recovery at the site of forearm free flap as assessed by objective clinical findings
Time Frame: baseline
|
Participants will be evaluated clinically using pinprick, light touch, and two-point discrimination tests.
An overall score will be reported.
|
baseline
|
Number of participants with normal sensory recovery at the site of forearm free flap as assessed by objective clinical findings
Time Frame: 3 months
|
Participants will be evaluated clinically using pinprick, light touch, and two-point discrimination tests.
An overall score will be reported.
|
3 months
|
Number of participants with normal sensory recovery at the site of forearm free flap as assessed by objective clinical findings
Time Frame: 6 months
|
Participants will be evaluated clinically using pinprick, light touch, and two-point discrimination tests.
An overall score will be reported.
|
6 months
|
Number of participants with normal sensory recovery at the site of forearm free flap as assessed by objective clinical findings
Time Frame: 12 months
|
Participants will be evaluated clinically using pinprick, light touch, and two-point discrimination tests.
An overall score will be reported.
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: James C Melville, DDS, The University of Texas Health Science Center, Houston
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 9, 2020
Primary Completion (Anticipated)
January 1, 2024
Study Completion (Anticipated)
January 1, 2024
Study Registration Dates
First Submitted
March 13, 2019
First Submitted That Met QC Criteria
March 13, 2019
First Posted (Actual)
March 15, 2019
Study Record Updates
Last Update Posted (Actual)
May 22, 2023
Last Update Submitted That Met QC Criteria
May 18, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HSC-DB-18-0760
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Head and Neck Neoplasms
-
Robert FerrisAmgenCompletedHead and Neck Cancer | Cancer of Head and Neck | Head Cancer | Neck Cancer | Neoplasms, Head and Neck | Cancer of the Head and Neck | Cancer of Neck | Upper Aerodigestive Tract Neoplasms | Neck Neoplasms | Cancer of the Head | Cancer of the Neck | UADT Neoplasms | Cancer of Head | Head Neoplasms | Head, Neck Neoplasms | Neoplasms, Head and other conditionsUnited States
-
Assiut UniversityRecruitingHead and Neck Cancer | Head and Neck Neoplasms | Cancer of Head and Neck | Neoplasms, Head and Neck | Cancer of the Head and NeckEgypt
-
IRCCS Policlinico S. MatteoNestlé Health Science Spain; Akern SrlCompletedHead-neck CancerItaly
-
University of California, San FranciscoCompleted
-
Thomas Jefferson UniversityCompletedHead and Neck CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedHead And Neck CancerUnited States
-
AZ Sint-Jan AVRecruiting
-
IntraGel TherapeuticsNot yet recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingHead and Neck CarcinomaUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisActive, not recruiting
Clinical Trials on Collagen Nerve Wrap Conduit
-
Axogen CorporationCompletedComparison of Processed Nerve Allograft and Collagen Nerve Cuffs for Peripheral Nerve Repair (RECON)Peripheral Nerve DiscontinuitiesUnited States
-
Axogen CorporationTerminatedTraumatic Nerve InjuryUnited States
-
Axogen CorporationRecruitingPeripheral Nerve InjuriesUnited States, Austria, Canada, United Kingdom